LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Mutation of the TGN1412 anti-CD28 Monoclonal Antibody Lower Hinge Confers Specific FcγRIIb Binding and Retention of Super-Agonist Activity.

Photo by jontyson from unsplash

The agonistic action of several immunomodulatory monoclonal antibodies (mAb) requires both target antigen binding and clustering of this mAb:target complex by the Fcs interacting with Fcγ receptors (FcγR), in particular… Click to show full abstract

The agonistic action of several immunomodulatory monoclonal antibodies (mAb) requires both target antigen binding and clustering of this mAb:target complex by the Fcs interacting with Fcγ receptors (FcγR), in particular FcγRIIb, on neighbouring bystander cells. Fc mutations were made in the IgG4-based TGN1412 anti-CD28 mAb to define the role of FcγR interactions in its "super-agonist" activity. The dual mutation, IgG4-ED269,270 AA, ablated interaction with all human FcγR and agonistic action was consequentially lost, confirming the FcγR-dependence on the action of TGN1412. The IgG4 lower hinge region (F234 L235 G236 G237 ) was modified by L235 E mutation (F234 E235 G236 G237 ), a mutation commonly used to ablate FcγR binding, including in approved therapeutic mAbs. However, rather than ablating all FcγR binding, IgG4-L235 E conferred specific binding to FcγRIIb, the inhibitory Fc receptor. Furthermore, in combination with the core hinge-stabilising mutation (IgG4-S228 P, L235 E), this mutation increased affinity for FcγRIIb compared to wild type IgG4. In addition to having FcγRIIb specificity, these engineered TGN1412 antibodies also retained their super-agonistic ability, demonstrating that CD28 and FcγRIIb-specific binding are together sufficient for agonistic function. The FcγRIIb-specific nature of IgG4-L235 E has utility for mAb-mediated immune agonism therapies that are dependent on FcγRIIb interaction and of anti-inflammatory mAbs in allergy and autoimmunity that harness FcγRIIb inhibitory signalling.

Keywords: igg4; tgn1412 anti; anti cd28; mutation; riib; hinge

Journal Title: Immunology and cell biology
Year Published: 2023

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.